Australia markets open in 8 hours 51 minutes

Enzon Pharmaceuticals, Inc. (EZ1.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
0.0590+0.0010 (+1.72%)
At close: 05:47PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
26
701
52
Operating expenses
Selling general and administrative
1,044
1,044
1,058
1,170
1,357
Total operating expenses
1,044
1,044
1,058
1,170
1,357
Operating income or loss
-1,044
-1,044
-1,032
-469
-1,305
Total other income/expenses net
-
-
646
7
1
Income before tax
1,217
1,217
-386
-462
-1,304
Income tax expense
-156
-156
-200
7
7
Income from continuing operations
1,373
1,373
-186
-469
-1,311
Net income
1,373
1,373
-186
-469
-1,311
Net income available to common shareholders
98
98
-1,461
-2,492
-1,771
Basic EPS
0.00
0.00
-0.02
-0.03
-0.03
Diluted EPS
0.00
0.00
-0.02
-0.03
-0.03
Basic average shares
74,215
74,215
74,215
74,215
51,100
Diluted average shares
74,215
74,215
74,215
74,215
51,100